The examination of efficacy of nasal steroid spray in IgG4 related disease.

The examination of efficacy of nasal steroid spray in IgG4 related disease. - The examination of efficacy of nasal steroid spray in IgG4 related disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003996

Enrollment

Registered

2010-09-01

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4 related disease

Interventions

Nasal spray containing steroid Nasal spray not containing steroid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who fulfilled the criteria and give written consent in this study. The patients with IgG4 related disease in stable condition.

Exclusion criteria

Exclusion criteria: Patients who considered to have risks for follow up without oral steroids therapy are excluded from this study. Patients who are judged inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
Improvement of clinical findings, serological and imaging assessments	—

Countries

Japan

Contacts

Public ContactHideaki Moteki

Shinshu University school of Medicine Department of Otorhinolaryngology

moteki@shinshu-u.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026